CALO', GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.163
AS - Asia 1.158
EU - Europa 971
SA - Sud America 6
AF - Africa 2
OC - Oceania 1
Totale 10.301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.153
SG - Singapore 769
FR - Francia 370
VN - Vietnam 278
FI - Finlandia 153
IT - Italia 151
GB - Regno Unito 108
CN - Cina 88
SE - Svezia 57
DE - Germania 56
IE - Irlanda 28
UA - Ucraina 15
NL - Olanda 10
CA - Canada 8
JP - Giappone 6
RU - Federazione Russa 5
BE - Belgio 4
BG - Bulgaria 4
CL - Cile 4
EG - Egitto 2
HK - Hong Kong 2
HU - Ungheria 2
IN - India 2
IR - Iran 2
JM - Giamaica 2
KR - Corea 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
GR - Grecia 1
ID - Indonesia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 10.301
Salva come PNG Salva come JPEG
Città #
Fairfield 2.186
Woodbridge 651
Cambridge 631
Houston 603
Singapore 580
Ashburn 523
San Diego 498
Seattle 463
Medford 389
Princeton 389
Des Moines 289
Wilmington 287
Dong Ket 278
Ann Arbor 197
Helsinki 150
Chandler 140
Santa Clara 120
Roxbury 116
Padova 44
Beijing 34
London 34
Dublin 28
Ferrara 22
Norwalk 22
Kharkiv 15
Borås 11
New York 9
Prescot 9
Modena 8
Acton 7
Kilburn 7
Milan 7
Rockville 7
Chiswick 6
Ferrara di Monte Baldo 6
Hounslow 6
New Bedfont 6
Rome 6
Los Angeles 5
Washington 5
Sofia 4
Brussels 3
Chicago 3
Cordovado 3
Misterbianco 3
Osaka 3
Piazzola sul Brenta 3
Southwark 3
Wandsworth 3
Austin 2
Bucheon-si 2
Budapest 2
Catania 2
Forest City 2
Hong Kong 2
Lappeenranta 2
Las Vegas 2
Legnaro 2
Marano sul Panaro 2
Montego Bay 2
Niederzier 2
Paris 2
Raleigh 2
Redwood City 2
Riva 2
Tanta 2
Tokyo 2
Agordo 1
Andover 1
Andria 1
Antwerpen 1
Atlanta 1
Auckland 1
Bari 1
Belluno 1
Bergamo 1
Boardman 1
Bologna 1
Brooklyn 1
Busto Arsizio 1
Campagna Lupia 1
Colombo 1
Deventer 1
Dover 1
Dronten 1
Fort Worth 1
Frankfurt am Main 1
Geislingen an der Steige 1
Grassano 1
Greenwich 1
Hanover 1
Innsbruck 1
Irving 1
Islington 1
Kashan 1
Kuala Lumpur 1
Kyoto 1
La Canada Flintridge 1
Landshut 1
Lincoln 1
Totale 8.891
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 153
Hyaluronic Acid Induces Activation of the κ-Opioid Receptor 120
A simple method for electrical field stimulation of cultured granule cells 61
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 57
Excitatory amino acids (EAAs) stimulate phosphatidylinositol turnover in adult rat striatal slices: interaction between NMDA and EAA metabotropic receptors 55
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 47
Novel Mixed NOP/Opioid Receptor Peptide Agonists 47
Pharmacological characterization of tachykinin tetrabranched derivatives 46
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 45
Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid 45
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 44
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 43
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 43
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 43
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 42
Pharmacological Assays for Investigating the NOP Receptor 42
Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux 42
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist 42
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 41
Actual concept of "probiotics": is it more functional to science or business? 41
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 41
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 41
Noradrenergic modulation of gamma-aminobutyric acid outflow from the human cerebral cortex 40
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 40
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders 40
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 40
Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity 40
Ligands Raise the Constraint That Limits Constitutive Activation in G Protein-coupled Opioid Receptors 39
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 39
Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: A comparative study with amphetamine and diazepam 39
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists 39
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 39
In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45 39
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides 38
Nociceptin Modulates Bronchoconstriction Induced by Sensory Nerve Activation in Mouse Lung 38
Circadian variation in attempted suicide by deliberate self-poisoning 38
Desensitisation of native and recombinant human urotensin-II receptors 38
Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression - studies using the ecdysone inducible mammalian expression system 38
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68) 38
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation 38
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505) 38
Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice 38
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation 38
Hypothalamic neuropeptide S receptor blockade decreases discriminative cue-induced reinstatement of cocaine seeking in the rat 37
A new ligand for the urotensin II receptor 37
Circadian variation in attempted suicide by deliberate self poisoning 37
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 37
NOCICEPTIN RECEPTOR ACTIVATION INHIBITS TACHYNERGIC NON ADRENERGIC NON CHOLINERGIC CONTRACTION OF GUINEA PIG ISOLATED BRONCHUS 37
Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat 37
Acute thrombosis of abdominal aorta in a petient under warfarin treatment 37
1999, Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors 37
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 37
Neuropeptide S counteracts 6-OHDA-induced motor deficits in mice 37
Urotensin II evokes neurotransmitter release from rat cerebrocortical slices 37
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 37
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 37
The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo. 37
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 37
Characterization of Halyomorpha halys TAR1 reveals its involvement in (E)-2-decenal pheromone perception 37
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor 36
The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S 36
[(pF)Phe(4), Arg(14), Lys(15)]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 36
Cyclic mu-opioid receptor ligands containing multiple N-methylated amino acid residues 36
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 36
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 36
The concise guide to pharmacology 2019/20: G protein-coupled receptors 36
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 36
Pharmacology of the Kallikrein-Kinin system 36
Pharmacological characterization of naloxegol: In vitro and in vivo studies 36
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS 35
Nociceptin/Orphanin FQ and its receptor - Potential targets for pain therapy? 35
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68 35
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies 35
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 35
Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults 35
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 35
Structure-activity study at positions 3 and 4 of human neuropeptide S 35
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice 35
Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112 35
Sudden death from pulmonary thromboembolism: chronobiological aspects 35
EMERGENCY ADMISSIONS OF OPIOID DRUG-ABUSERS FOR OVERDOSE - A CHRONOBIOLOGICAL STUDY OF ENHANCED RISK 35
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 35
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 34
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol 34
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 34
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 34
Modulation of Silent and Constitutively Active Nociceptin/Orphanin FQ Receptors by Potent Receptor Antagonists and Na+ Ions in Rat Sympathetic Neurons 34
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma 34
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 34
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 34
Plant-derived peptides rubiscolin-6, soymorphin-6 and their c-terminal amide derivatives: Pharmacokinetic properties and biological activity 34
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 34
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 34
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 34
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 34
Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors 34
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 34
Pharmacology of endothelins: vascular preparations for studying ETA and ETB receptors 34
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze 34
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 33
Totale 4.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.655
article - articoli 62.435
book - libri 142
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 700
selected - selezionate 0
volume - volumi 972
Totale 129.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 1 3 2 2 3 5 4 5 0
2020/20212.147 2 3 1 3 1 0 0 2 846 915 76 298
2021/20225.534 146 1.519 395 274 252 73 430 479 264 43 615 1.044
2022/20231.017 616 38 15 30 57 75 11 38 55 9 26 47
2023/2024794 2 48 65 63 59 54 55 15 13 16 97 307
2024/20251.170 10 669 491 0 0 0 0 0 0 0 0 0
Totale 10.722